Figure 2From: Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessmentPlasma concentrations of DCU after 30 mg/kg (—) and 10 mg/kg (- - -) oral nanosuspension and 3 mg/kg (· · ·) suspension administration. Free plasma concentrations remained above the in vitro IC50 for approximately 2 h for the nanosuspension dosesBack to article page